2026 Regular Session
HB1223
Establishes the Louisiana Clinical Trial Competitiveness and Patient Access Act
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Recorded floor votes
4 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
May 11, 2026 · House
House Vote on HB 1223 FINAL PASSAGE (#1141)
Passed ⭐ Substantive final action
93 yea–0 nay · 12 absent
May 11, 2026 · House
House Vote on HB 1223 FINAL PASSAGE (#1141)
Passed ⭐ Substantive final action
94 yea–0 nay · 11 absent
May 26, 2026 · Senate
Senate Vote on HB 1223 FINAL PASSAGE (#1354)
Passed ⭐ Substantive final action
38 yea–0 nay · 1 absent
May 29, 2026 · House
House Vote on HB 1223 CONCUR IN SENATE AMENDMENTS (#1713)
Passed
98 yea–0 nay · 7 absent
Committee referrals
May 13, 2026 · Senate
Commerce, Consumer Protection, and International Affairs
April 1, 2026 · House
Commerce
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Effective date: 06/09/2026.
-
House Signed by the Governor. Becomes Act No. 886.
-
House Sent to the Governor for executive approval.
-
Senate Signed by the President of the Senate.
-
House Enrolled and signed by the Speaker of the House.
-
House Read by title, roll called, yeas 98, nays 0, Senate amendments concurred in.
-
House Scheduled for concurrence on 05/29/2026.
-
House Received from the Senate with amendments.
-
Senate Rules suspended. The amended bill was read by title, passed by a vote of 38 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled. View roll call
-
Senate Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
-
Senate Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
-
Senate Reported with amendments.
-
Senate Read second time by title and referred to the Committee on Commerce, Consumer Protection and International Affairs.
-
Senate Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
-
House Read third time by title, amended, roll called on final passage, yeas 94, nays 0. Finally passed, title adopted, ordered to the Senate.
-
House Called from the calendar.
-
House Scheduled for floor debate on 05/11/2026.
-
House Notice given.
-
House Read by title, returned to the calendar.
-
House Called from the calendar.
-
House Scheduled for floor debate on 05/07/2026.
-
House Notice given.
-
House Read by title, returned to the calendar.
-
House Called from the calendar.
-
House Scheduled for floor debate on 05/05/2026.
-
House Notice given.
-
House Read by title, returned to the calendar.
-
House Scheduled for floor debate on 04/27/2026.
-
House Read by title, amended, ordered engrossed, passed to 3rd reading.
-
House Reported with amendments (12-0).
-
House Read by title, under the rules, referred to the Committee on Commerce.
-
House Read by title. Lies over under the rules.